Approval · Notice of Compliance 12362 · 2011
TEVA-TIMOLOL: Notice of Compliance 12362
Issued May 20, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12362
- Date
- May 20, 2011
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Antihypertensive / Antianginal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-TIMOLOL | 01947796 | Cancelled Post Market |
| TEVA-TIMOLOL | 01947818 | Cancelled Post Market |
| TEVA-TIMOLOL | 01947826 | Cancelled Post Market |
Medicinal ingredients
- TIMOLOL MALEATE 5 MG per TAB
- TIMOLOL MALEATE 10 MG per TAB
- TIMOLOL MALEATE 20 MG per TAB